OnKure Therapeutics OKUR Cash Flow Statement (2020-2026)

NASDAQ OKUR
$3.27 -0.11 (-3.27%)
As of: Sep 10, 2026 · 3:59 PM EDT
Reported Financials

OnKure Therapeutics Quarterly Cash Flow Statement

Periods 26 quarters
Latest Jun 2026

OnKure Therapeutics reported cash from operations of -$10.35M and free cash flow of -$10.36M for the quarter ended Jun 2026, up 22.0% year over year. This cash flow statement covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-12.75M-10.62M-13.02M-12.43M-13.84M-14.56M-16.12M-21.04M-20.89M21.11M-9.54M-14.37M-11.73M-18.76M-15.93M-16.32M-15.50M-14.13M-15.62M-16.90M
Share-based Compensation
3.22M1.42M4.26M4.40M4.47M1.22M6.01M6.00M6.10M-3.57M4.80M4.67M0.47M2.53M3.05M3.05M2.96M3.02M2.78M4.08M
Cash from Operations
-9.67M-10.02M-9.00M-11.96M-10.79M-15.61M-9.05M-16.11M-18.77M9.38M-10.63M-6.47M-10.66M-23.35M-14.01M-13.27M-13.04M-11.51M-12.94M-10.35M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles
-0.08M-0.09M-0.00M0.02M0.15M0.65M0.77M1.24M1.54M-3.41M0.04M0.04M0.04M0.09M0.09M0.10M0.10M0.10M0.10M0.10M
Amortization of Deferred Charges
0.13M0.01M
Depreciation & Amortization (CF)Depreciation & Amortization
0.01M0.02M0.02M0.02M0.02M0.03M0.04M0.04M0.04M0.29M0.11M0.12M0.11M0.12M0.12M0.12M0.11M0.10M0.10M0.09M
Change in Working Capital
Change in Accured Expenses
2.98M-0.04M1.25M0.47M1.11M-2.32M3.40M3.29M-0.18M-4.79M-1.74M7.46M-0.57M-11.08M-1.68M-1.20M-1.36M-0.30M-0.91M1.83M
Other Working Capital Changes
1.12M1.13M-2.01M1.11M-0.24M0.27M-1.95M0.41M-0.48M3.52M-0.44M1.70M-1.42M-2.10M-0.73M-0.33M0.01M0.52M-0.28M-0.09M
Investing Activities
Capital Expenditures
0.08M0.09M0.04M0.02M0.03M0.25M0.17M0.01M0.02M0.05M0.01M0.01M0.02M0.01M0.02M0.01M0.01M0.01M0.01M0.00M
Change in Acquisitions & Divestments
21.50M9.00M6.00M7.60M47.00M35.00M79.00M81.00M59.00M45.00M25.00M-113.08M
Cash from Investing Activities
-4.51M8.15M5.43M9.08M-45.44M-26.92M18.51M-69.01M21.25M29.01M-0.01M-0.01M-0.02M15.91M-0.02M-0.01M-0.01M-0.01M-0.01M-9.87M
Financing Activities
Other financing activities
0.00M-0.03M0.10M0.13M-4.21M-0.39M0.01M0.01M0.01M0.00M
Debt Issuance and Repayment
Long-Term Debt Issuances
Change in Capital Stock
Net Shares Issued and Repurchased
3.54M0.23M2.07M0.14M0.98M0.50M1.78M0.71M0.77M0.03M
Net Equity Issued and Repurchased
0.00M-0.03M0.01M1.01M57.85M-5.08M
Misc.
Cash from Financing Activities
0.22M0.12M0.01M0.04M0.10M0.33M1.01M63.81M0.17M-11.87M0.01M5.87M0.01M110.25M-0.08M0.24M146.00M-5.38M
Change in Cash
-13.96M-1.75M-3.57M-2.83M-56.13M-42.20M10.47M-21.31M2.66M26.52M-10.63M-0.61M-10.67M102.80M-14.10M-13.29M-13.04M-11.28M133.06M-25.60M
Free Cash Flow
-9.75M-10.11M-9.04M-11.98M-10.82M-15.86M-9.22M-16.12M-18.79M9.33M-10.64M-6.48M-10.68M-23.37M-14.02M-13.29M-13.04M-11.52M-12.94M-10.36M
Net Cash Flow
-13.96M-1.75M-3.57M-2.83M-56.13M-42.20M10.47M-21.31M2.66M26.52M-10.63M-0.61M-10.67M102.80M-14.10M-13.29M-13.04M-11.28M133.06M-25.60M